Apotex Inc. v. Sanofi-Aventis et al., (2014) 456 N.R. 279 (FCA)

This document cites

• Teva Canada Ltd. v. Nycomed Canada Inc. et al., (2012) 433 N.R. 197 (FCA)
• Apotex Inc. v. Merck Canada Inc. et al., [2012] F.T.R. Uned. 607 (FC)
• Sanofi-Aventis Canada Inc. et al. v. Teva Canada Ltd., (2012) 410 F.T.R. 145 (FC)
• Apotex Inc. v. Sanofi-Aventis et al., (2012) 410 F.T.R. 78 (FC)
• Sanofi-Aventis Canada Inc. et al. v. Teva Canada Ltd., (2012) 410 F.T.R. 1 (FC)



See all quotations

• Apotex Inc. v. Nycomed Canada Inc., (2012) 434 N.R. 43 (FCA)
• Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. et al., (1994) 176 N.R. 48 (FCA)
• Aventis Pharma Inc. v. Apotex Inc. et al., (2005) 278 F.T.R. 1 (FC)
• Ferring Inc. v. Canada (Minister of Health) et al., (2007) 370 N.R. 263 (FCA)
• Apotex Inc. v. Canada (Minister of National Health and Welfare) et al., (1997) 219 N.R. 151 (FCA)
• Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
• Apotex Inc. v. Sanofi-Aventis et al., [2014] N.R. Uned. 38
• Sanofi-Aventis Canada Inc. v. Canada (Minister of Health) et al., (2007) 360 N.R. 321 (FCA)
• Bayer AG et al. v. Canada (Minister of National Health and Welfare) et al., (1997) 142 F.T.R. 130 (TD)
• Eli Lilly & Co. et al. v. Novopharm Ltd. et al., (1997) 137 F.T.R. 32 (TD)
• Sanofi-Aventis Inc. et al. v. Laboratoire Riva Inc. et al., 2007 FC 532
• Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., (2011) 420 N.R. 115 (FCA)
• Apotex Inc. v. Sanofi-Aventis Canada Inc., [2007] N.R. Uned. 2 (FCA)
• Ferring Inc. v. Canada (Minister of Health) et al., (2007) 310 F.T.R. 185 (FC)
• Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
• Eli Lilly & Co. et al. v. Novopharm Ltd. et al., (1998) 227 N.R. 201 (SCC)
• Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd. et al., (2007) 366 N.R. 231 (FCA)
• Apotex Inc. v. Takeda Canada Inc., (2013) 444 F.T.R. 120 (FC)
• Sanofi-Aventis Canada Inc. et al. v. Teva Canada Ltd., (2014) 456 N.R. 241 (FCA)
• Sanofi-Aventis Canada Inc. v. Novopharm Ltd. et al., (2007) 364 N.R. 325 (FCA)
• Apotex Inc. v. Nycomed Canada Inc., [2011] F.T.R. Uned. 878
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., 2005 FC 1381
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., 2006 FCA 328
• Apotex Inc. v. Merck & Co. et al., (2009) 391 N.R. 336 (FCA)
• Sanofi-Aventis Canada Inc. et al. v. Teva Canada Ltd., (2014) 459 N.R. 179 (FCA)
• Ratych v. Bloomer, (1990) 107 N.R. 335 (SCC)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., [2010] F.T.R. Uned. 895 (FC)
• Sanofi-Aventis Canada Inc. v. Novopharm Ltd. et al., 2006 FC 1135
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., (2005) 283 F.T.R. 171 (FC)
• AstraZeneca Canada Inc. v. Canada (Minister of Health) et al., (2006) 354 N.R. 88 (SCC)